{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01524770","recordId":"NCT01524770","peptideSlug":"dulaglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01524770-dulaglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01524770.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01524770.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2012-01-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2012-01-31","publishedAt":"2026-08-23","recordId":"NCT01524770","recordSha256":"182c5dd568188945fbc028816ddb2df95b238abf287876e61ea996871eb4d1ad","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01524770?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2012-02-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2012-02-10","publishedAt":"2026-08-23","recordId":"NCT01524770","recordSha256":"79ae7a28cd64d867ea0f795af8249318891cd45fbe7a4a2d7afb4c1d6a7f3558","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01524770?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2012-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2012-03-27","publishedAt":"2026-08-23","recordId":"NCT01524770","recordSha256":"b020fb64ca241e415b1e7a2e62009ce5d179ac927fd75cfbd980a69f98e090ed","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01524770?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2012-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2012-04-03","publishedAt":"2026-08-23","recordId":"NCT01524770","recordSha256":"735941a242a8f40f3a5b93de2b35825a1b10f23d27ab4a02f334b16299c64159","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01524770?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2012-05-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2012-05-07","publishedAt":"2026-08-23","recordId":"NCT01524770","recordSha256":"b1665afe71d3449d2e8cc124ca837a214e800258a0494db66b9668f4bbbeeb58","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01524770?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2012-05-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2012-05-30","publishedAt":"2026-08-23","recordId":"NCT01524770","recordSha256":"c77cf2b952e1687855fe6c9f30b75da08e1c45054c94dbe331b24815bdd3b857","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01524770?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2012-07-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"dulaglutide","submittedDate":"2012-07-02","publishedAt":"2026-08-23","recordId":"NCT01524770","recordSha256":"293c3742e816c0ea73bb0d1b18009a75d628262545ccbe1756965d8e252c9671","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01524770?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2014-10-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"dulaglutide","submittedDate":"2014-10-21","publishedAt":"2026-08-23","recordId":"NCT01524770","recordSha256":"c551645a6e7c048b85a1094f178246335db8bf2b8cd940e6baebc69e2c285c7d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01524770?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"96ab807d70aac50d8f7c4723a5d5ef254385fc88a4fa5f286141528d5d9cdb31"}}